Global Heparin Market 2016-2020 report is the latest addition to Sandlerresearch.org industry research reports collection, Heparin, a disaccharide anticoagulant or blood thinner, prevents the formation of blood clots. It is produced in the body by basophils and mast cells. It is stored within mast cells and secreted at the injury site. Though it has no effect on already formed clots, it enables the body’s natural clot lysis mechanisms to dissolve clots. It can also be taken from outside as a drug. Heparin can be derived from natural sources such as pig intestine and bovine lungs.
The analysts forecast global heparin market to grow at a CAGR of 4.74% during the period 2016-2020.
Heparin is divided into two types based on the fractionation process. Both types have medical use, with the selection done based on preference for a particular condition.
UFH: It is directly obtained from natural sources, without undergoing any fractionation.
LMWH: It is derived by depolymerizing UFH. The pharmacodynamics properties of LMWH are more predictable when compared to UFH.
Inquire for more details @ http://www.sandlerresearch.org/inquire-before-buying?rname=52723 .
Apart from these, another category of molecules, ULMWH are available. They are structurally related to LMWHs, but differ in the composition of monosaccharides and oligosaccharides. Therefore, they have different average molecular weights from LMWH.
The report, Global Heparin Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key players in the Global Heparin Market are GlaxoSmithKline plc (GSK), Leo Pharma A/S, Pfizer Inc., and Sanofi. Other Prominent Vendors in the market are: Alchemi, Baxter, BMS, Boehringer Ingelheim, Celgene, Cosmo Pharmaceuticals, Dr.Reddy's Laboratories, Eisai, Fresenius, GSK, Hospira, Laboratorios Rovi Pharmaceuticals, Lee's Pharmaceutical, Momenta Pharmaceuticals, Mylan, Novartis, Ockham Biotech, Perospher, PolyMedix, Portola Pharmaceutical, ProStrakan Group, Sagent Pharmaceticals, Sigma Tau Pharmaceuticals, UCB, and Urigen Pharmaceuticals.
Purchase a copy of Global Heparin Market 2016-2020 report @ http://www.sandlerresearch.org/purchase?rname=52723 for US $2500.
Further, the report states that patent expiries of major marketed products leads to a decline in sales, affecting the overall market growth.
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for heparin drugs
Exhibit 03: Differences between porcine heparin and bovine heparin
Exhibit 04: Process of blood coagulation
Exhibit 05: Mechanism of action of heparin
Exhibit 06: Pipeline portfolio: Heparin drugs
Exhibit 07: Market share of global heparin market in global anticoagulant drugs market 2015
Exhibit 08: Global anticoagulant drugs market 2015-2020 ($ billions)
Exhibit 09: Global heparin market 2015-2020 ($ billions)
Exhibit 10: Five forces analysis
Exhibit 11: Global heparin market in CPB surgeries 2015-2020 ($ millions)
Exhibit 12: Process of crude heparin production in China
Exhibit 13: Segmentation of global heparin market by product type 2015
Exhibit 14: Segmentation of global heparin market by ROA
Exhibit 15: Segmentation of global heparin market based on geography 2015 and more..
Inquire for Discount @ http://www.sandlerresearch.org/discount?rname=52723
Sandlerresearch.org is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.